Women want choices: Opinions from the Share.Learn.Shape global internet survey about multipurpose prevention technology (MPT) products in development
Women need multipurpose prevention technologies (MPTs) to simultaneously prevent sexually transmitted infections (STIs), including HIV, with or without contraception. User feedback early in product development is critical for maximizing uptake and continuation. Our global online survey (April 2017–December 2018) explored women’s opinions about MPT formulations in development (e.g., fast-dissolving vaginal inserts, vaginal films, intravaginal rings, injectables, implants), preferences for long-acting or “on-demand” methods, and interest in a contraceptive MPT versus products for HIV/STI prevention alone. Of the 630 women in our final analysis (mean 30 years old; range 18–49), 68% were monogamous, 79% completed secondary education, 58% had ≥ 1 child, 56% were from sub-Saharan Africa and 82% preferred a cMPT versus HIV/STI prevention alone. There were no clear preferences for any specific product or product type (long-acting, on-demand, daily). No single product will appeal everyone, however, adding contraception is likely to increase uptake of HIV/STI prevention methods for most women.
Friedland, Barbara, Marlena Gehret Plagianos, Craig Savel, Virginia Kallianes, C. Martinez, Lorna Begg, K.M. Guthrie, D. Venkatasetty, J. Pickett, and Lisa Haddad. 2023. "Women want choices: Opinions from the Share.Learn.Shape global internet survey about multipurpose prevention technology (MPT) products in development," AIDS and Behavior, https://doi.org/10.1007/s10461-022-03951-8.